DYRK1A as a novel target for glioblastoma therapies

  • Johns, Terry (Primary Chief Investigator (PCI))
  • Kassiou, Michael (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/1631/12/18

Funding

  • National Health & Medical Research Council (NHMRC): AUD80,000.00